Riskpilot← Back to searchSign inGet full accessUGH Medical AB
ABActiveOrg 5593256018Norrbackagatan 31Other education n.e.c. · NACE 8559Est. 20210 employees
Revenue 2025
SEK 1,1M
+12% vs 2024
EBITDA margin
85.8%
+19% vs 2024
Equity ratio
72.1%
Financial strength
Net profit 2025
SEK 746K
+20% vs 2024
| Revenue | SEK 1,1M | +12% |
| EBITDA | SEK 932K | +19% |
| Net profit | SEK 746K | +20% |
| Total assets | SEK 1,8M | +30% |
| Equity | SEK 1,3M | +44% |
| Employees | 0 | — |
Legal name
UGH Medical AB
Org number
5593256018
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
1 juli 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Undervisning inom medicinsk vetenskap. Konsult inom hälsorelaterade områden. Vetenskaplig kommunikation (exempelvis mediaframträdanden och försäljning av böcker). Socialmedia/online-verksamhet med fokus på vardagsliv och barnuppfostran i Sverige och Japan.
Address
Norrbackagatan 31
Email
peter.ueda@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 168 | 674 | 972 | 1 086 |
| Staff expenses | — | −25 | −30 | −20 |
| EBITDA | 130 | 517 | 784 | 932 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 130 | 517 | 784 | 932 |
| Net financials | — | −0 | −1 | −1 |
| Profit before tax | 130 | 517 | 783 | 931 |
| Tax | −27 | −107 | −162 | −185 |
| Net profit | 103 | 411 | 621 | 746 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 191 | 803 | 1 399 | 1 815 |
| Equity | 128 | 539 | 910 | 1 310 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 63 | 265 | 490 | 506 |
| Total debt | 63 | 265 | 490 | 506 |
EBITDA margin
85.8%
This company
15.8%
Market median
+443% vs market
20222025
Equity ratio
72.1%
This company
38.2%
Market median
+89% vs market
20222025
Return on equity
57.0%
This company
18.4%
Market median
+210% vs market
20222025
Net profit margin
68.7%
This company
8.1%
Market median
+748% vs market
20222025
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
20222025
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-02-28
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of UGH Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Olof Jakobsson | Deputy Board Member | 0 companies |
| Peter Jakobsson Ueda | Board of Directors | 0 companies |